natgillin/translations-raw huggingface dataset:
The recommended dose to treat COPD is one inhalation (92 micrograms of fluticasone furoate and 22 micrograms of vilanterol) once daily at the same time each day. 
KOPB Priporočeni odmerek za zdravljenje KOPB je ena inhalacija (92 mikrogramov flutikazonfuroata in 22
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Revinty Ellipta 92 micrograms/22 micrograms inhalation powder fluticasone furoate/vilanterol 
IME ZDRAVILA IN POT(I) UPORABE Revinty Ellipta 92 mikrogramov/22 mikrogramov prašek za inhaliranje, odmerjeni flutikazonfuroat/vilanterol za inhaliranje
Revinty Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed Revinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed 
Navodilo za uporabo Revinty Ellipta 92 mikrogramov/22 mikrogramov prašek za inhaliranje, odmerjeni Revinty Ellipta 184 mikrogramov/22 mikrogramov prašek za inhaliranje, odmerjeni flutikazonfuroat/vilanterol
Your Revinty Ellipta inhaler carton contains 
Škatla vašega zdravila Revinty Ellipta vsebuje
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Revinty Ellipta 184 micrograms/22 micrograms inhalation powder fluticasone furoate/vilanterol 
IME ZDRAVILA IN POT(I) UPORABE Revinty Ellipta 184 mikrogramov/22 mikrogramov prašek za inhaliranje, odmerjeni flutikazonfuroat/vilanterol za inhaliranje
NAME OF THE MEDICINAL PRODUCT Revinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed 
Revinty Ellipta 184 mikrogramov/22 mikrogramov prašek za inhaliranje, odmerjeni
NAME OF THE MEDICINAL PRODUCT Revinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed fluticasone furoate/vilanterol 
Revinty Ellipta 184 mikrogramov/22 mikrogramov prašek za inhaliranje, odmerjeni flutikazonfuroat/vilanterol
Very common Rare 
Zelo pogosti neželeni učinki
NAME OF THE MEDICINAL PRODUCT Revinty Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed fluticasone furoate/vilanterol 
Revinty Ellipta 92 mikrogramov/22 mikrogramov prašek za inhaliranje, odmerjeni flutikazonfuroat/vilanterol
While you're using Revinty Ellipta 
Med uporabo zdravila Revinty Ellipta
There were no clinically relevant effects of the fluticasone furoate/vilanterol combination on beta-adrenergic systemic effects (heart rate or serum potassium) in subjects with mild or moderate hepatic impairment (vilanterol, 22 micrograms) or with severe hepatic impairment (vilanterol, 12.5 micrograms) compared with healthy subjects. 
(12,5 mikrogramov vilanterola) v primerjavi z zdravimi preiskovanci ni bilo klinično pomembnih učinkov kombinacije flutikazonfuroata/vilanterola na sistemske beta-adrenergične učinke (srčna frekvenca ali kalij v serumu).
- For the 92/22mcg dose: each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 92 micrograms of fluticasone furoate and 22 micrograms of vilanterol (as trifenatate). 
Ena inhalacija zagotavlja oddani odmerek (odmerek, ki zapusti ustnik) 92 mikrogramov flutikazonfuroata in 22 mikrogramov vilanterola (v obliki trifenatata).
MARKETING AUTHORISATION NUMBER(S) EU/1/14/929/006 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/14/929/006
Pyrexia 
Ellipta.
MARKETING AUTHORISATION NUMBER(S) EU/1/14/929/001 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/14/929/001
• tremor • anxiety 
• tresavica, • tesnoba.
MARKETING AUTHORISATION NUMBER(S) EU/1/14/929/004 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/14/929/004
MARKETING AUTHORISATION NUMBER(S) EU/1/14/929/003 
ŠTEVILKA(E) DOVOLJENJA(DOVOLJENJ) ZA PROMET EU/1/14/929/003
HZA106829 was 24 weeks in duration and evaluated the efficacy of fluticasone furoate/vilanterol 184/22 micrograms [n=197] and FF 184 micrograms [n=194]) both administered once daily compared with FP 500 micrograms twice daily [n=195]. 
[n = 197] in 184 mikrogramov FF [n = 194], obeh uporabljenih enkrat na dan, v primerjavi s FP 500 mikrogramov dvakrat na dan [n = 195].
- if you are pregnant. 
- Če ste noseči.
- if you had a heart attack less than a month ago. 
- Če imeli srčni napad pred manj kot enim mesecem.
Considering the design of the study, no conclusions can be drawn from the results of the separate analysis. 
Glede na zasnovo študije ni možno narediti zaključkov iz rezultatov ločene analize.
Other types of interactions 
Druge vrste interakcij
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 29 November 2004 
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET 29. november 2004
The first two numbers denote the month, the last two numbers denote the year. 
Prvi dve številki pomenita mesec, zadnji dve številki pa leto.
or as a continuous infusion of 5 mg/min. 
ali kot neprekinjeno infuzijo 5 mg/min.
This could mainly be attributed to the increased incidence of peripheral oedema. 
To je v glavnem možno pripisati povečani pojavnosti perifernega edema.
Do not stop the treatment early without consulting your doctor. 
Zdravljenja ne smete prekiniti prezgodaj brez posvetovanja s svojim zdravnikom.
As a result of this treatment, the serum calcium levels can reach or exceed the upper limit of normal levels. 
Kot posledica tega zdravljenja lahko serumske ravni kalcija dosežejo ali presežejo zgornje mejne vrednosti normalnih ravni.
It is not known if this can lead to an effect in the infant. 
Ni znano, ali lahko to vpliva na dojenčka.
If the effects are inadequate, the treatment can be continued, with ECG monitoring. 
Če so učinki nezadostni, se lahko zdravljenje nadaljuje s spremljanjem EKG.
Quinupristin/Dalfopristin 
Kinupristin/dalfopristin
BATCH NUMBER Batch: 
ŠTEVILKA SERIJE Batch:
Therefore, the ability to drive or use machines can be reduced. 
Zato lahko zmanjša sposobnost vožnje in upravljanja s stroji.
To date, limited data on exposed first trimester pregnancies have not shown an increase in the frequency of congenital anomalies compared to the frequency in the general population. 
Dosedanji omejeni podatki pri izpostavljenosti v prvih treh mesecih nosečnosti niso pokazali povečanja pogostosti kongenitalnih anomalij v primerjavi s pogostostjo pri splošni populaciji.
International Pharmaceutical Services (IPS), Jozef Nellenslei 10, 2100 Deurne, Belgium 
International Pharmaceutical Services (IPS), Jozef Nellenslei 10, 2100 Deurne, Belgija
Constipation (obstruction) can occur. 
Lahko pride do zaprtja (obstrukcije).
- if you use the medicine rifampicin (a medicine used in certain infection disease). 
- Če jemljete zdravilo rifampicin (zdravilo, ki se uporablja za določene nalezljive bolezni).
6.6 Instructions for use and handling <and disposal> No special requirements. 
6.6 Navodila za pripravo in ravnanje z zdravilom in odlaganje Ni posebnih zahtev.
Frequency of undesirable effects is classified as very common (>10%); common (1-10%); uncommon (0.1-1%); rare (0.01-0.1%) or very rare including isolated reports (<0.01%). 
Neželeni učinki se po pogostnosti razvrščajo kot zelo pogosti (> 10 %); pogosti (1-10 %); občasni (0,1-1 %); redki (0,01-0,1 %) ali zelo redki, vključno s posameznimi primeri (< 0,01 %).
You may not use this medicine in such a case. 
V tem primeru ne smete uporabiti zdravila.
Pregnancy (See section 4.6). 
- Nosečnost (glejte poglavje 4.6).
- The Summary of Products Characteristic, labelling and package leaflet proposed by the applicant has been assessed based on the documentation submitted, the scientific discussion within the Committee and the new wording proposed in the updated Guideline on SPC dated October 2005 and the latest QRD templates version 7 
- Povzetek glavnih značilnosti zdravila, označevanje in navodila za uporabo, ki jih je predlagal vlagatelj, so bili ovrednoteni na podlagi predložene dokumentacije, znanstvene razprave znotraj Odbora in novega besedila, predlaganega v posodobljenih smernicah o SPC iz oktobra 2005 ter zadnje različice 7 predloge QRD.
- if you have a low blood pressure (hypotension). 
- Če imate nizek krvni tlak (hipotenzijo).
However, if it is already almost time to take the next dose (i.e. you skipped one day), skip the missed dose and continue to take the medicine according to the normal dosage scheme. 
Če pa je skoraj čas za naslednji odmerek (npr. če ste izpustili en dan), preskočite pozabljeni odmerek in nadaljujte z jemanjem zdravila po običajnem urniku.
- if the pumping force of the heart is insufficient (decompensatio cordis). 
- Če je črpalna sposobnost srca nezadostna (dekompenzacija srca).
The dosage of these medicines should be determined by the patient's response. 
Odmerjanje teh zdravil se mora določiti na podlagi odziva bolnika.
Adverse reactions are often dose related and occur most frequently in the first couple of weeks after initiation of therapy. 
Neželeni učinki so pogosto odvisni od odmerka in se najpogosteje pojavljajo v prvih parih tednih po začetku zdravljenja.
An almost constant release rate provides a relatively constant concentration of active substance in plasma, without major differences between maximal and minimal levels. 
Skoraj stalna hitrost sproščanja omogoča relativno konstantno koncentracijo zdravilne učinkovine v plazmi brez poglavitnih razlik med maksimalnimi in minimalnimi ravnmi.
OTHER SPECIAL WARNING(S), IF NECESSARY Contains lactose. 
DRUGA POSEBNA OPOZORILA, ČE SO POTREBNA Vsebuje laktozo.
The following side effects can occur: 
Lahko se pojavijo naslednji neželeni učinki:
For hypertension: 
Za hipertenzijo:
However, plasmaferesis can be recommended (high plasma protein-binding, relatively small volume of distribution). 
Priporočljiva pa je lahko plazmafereza (visoka vezavnost plazemskih beljakovin, relativno majhen volumen porazdelitve).
Furthermore, a deterioration of heart failure can occur. 
Poleg tega lahko pride do poslabšanja srčnega popuščanja.
In addition, in some cases, the use of nifedipine in order to treat pregnant hypertensive women is necessary. 
Poleg tega je v nekaterih primerih uporaba nifedipina pri zdravljenju nosečih hipertenzivnih ženskah potrebna.
In individual cases of concomitant use, neuromuscular block has been observed. 
V posameznih primerih sočasne uporabe so opazili nevromuskularni blok.
For the treatment of all grades of hypertension. 
Za zdravljenje vseh stopenj hipertenzije.
- if your blood pressure is continuing to rise despite treatment (malignant hypertension). 
- Če se vaš krvni tlak kljub zdravljenju še naprej zvišuje (maligna hipertenzija).
This should be considered during treatment of hypertension. 
Ta učinek je treba upoštevati pri zdravljenju hipertenzije.
Dosage in case of reduced liver function If your liver function is lower than normal, your doctor can prescribe a lower dosage. 
Odmerjanje v primeru motenj delovanja jeter Če je delovanje vaših jeter manjše kot normalno, vam bo zdravnik predpisal nižji odmerek.
A total of 6321 patients (55-80 years) were treated during 3 to 4.8 years with Nifedipine Retard or a standard combination of diuretics (hydrochlorothiazide 25 mg + amiloride 5 mg). 
Skupno 6321 bolnikov (55-80 let) je bilo zdravljenih 3 do 4,8 let z zdravilom Nifedipine Retard ali standardno kombinacijo diuretikov (hidroklorotiazid 25 mg + amilorid 5 mg).
The metabolites are pharmacologically inactive and non-toxic. 
Presnovki niso farmakološko aktivni in niso toksični.
Nifedipine is rapidly and almost completely absorbed (>90%). 
Nifedipin se hitro in skoraj povsem absorbira (> 90 %).
Safety in malignant hypertension is not established. 
Varnost uporabe pri maligni hipertenziji ni ugotovljena.
Antihypertensive medicines 
Antihipertenzivna zdravila
In conclusion, the warning related to women of childbearing potential proposed by the applicant in section 4.6 Pregnancy and lactation is relevant and sufficient. 
Zaradi tega je opozorilo, ki ga za ženske v rodni dobi predlaga vlagatelj v poglavju 4.6 Nosečnost in dojenje, smiselno in zadostno.
For a full list of excipients, see section 6.1. 
Za celoten seznam pomožnih snovi glejte 6.1.
The following posology is recommended for adults: 
Za odrasle so priporočeni naslednji odmerki:
- in case of in vitro fertilisation (IVF). 
- V primeru oploditve in vitro (IVF - »in vitro fertilisation«).
Eventually, unconsciousness can occur. 
Pride lahko tudi do nezavesti.
- if you use a stoma. 
- Če uporabljate stomo.
You should not chew or break the tablets. 
Tablet ne smete prežvečiti ali zdrobiti.
The incidence of heart failure shows a difference between both treatments (0.9% versus 0.3%). 
Pri pojavnosti odpovedi srca se je pojavila razlika med zdravljenjema (0,9 % proti 0,3 %).
- if you experience severe chest pains, or if the chest pains worsen. 
- Če imate hude bolečine v prsih ali če bolečine v prsih postanejo močnejše.
Thus, the proposed wording in section 4.6. of the SmPC to avoid breastfeeding during treatment when necessary, is sufficient. 
Zatorej zadostuje predlagano besedilo v poglavju 4.6 SmPC, da se je treba med zdravljenjem odpovedati dojenju, kadar je potrebno.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. 
Če vam je vaš zdravnik povedal, da imate intoleranco za nekatere sladkorje, obvestite svojega zdravnika preden boste vzeli to zdravilo.
Special care is needed in case of very low blood pressure (severe hypotension with systolic pressure below 90 mmHg). 
Posebno previdno je treba obravnavati primere zelo nizkega krvnega tlaka (huda hipotenzija s sistoličnim tlakom pod 90 mm Hg).
For chronic stable angina pectoris (exertion-induced angina): 
Za kronično stabilno angino pektoris (angina ob naporu):
- if you suffer from unstable angina pectoris. 
- Če imate nestabilno angino pektoris.
- if you have diabetes. 
- Če imate sladkorno bolezen.
Intravenous magnesium sulphate 
Intravensko dajanje magnezijevega sulfata
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, notably rifampicin, including medicines obtained without a prescription. 
Obvestite svojega zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
Nifedipine is contraindicated during pregnancy and not recommended in women who intend to get pregnant in the near future. 
Nifedipin je kontraindiciran med nosečnostjo in ni priporočljiv za ženske, ki nameravajo zanositi v bližnji prihodnosti.
Carton box with blister strips made of PVC/PVDC and aluminium foil. 
Kartonska škatla s pretisnimi omoti iz PVC/PVDC in aluminijaste folije.
fever in the first few days after initiating therapy. 
povišana telesna temperatura v prvih nekaj dneh po začetku zdravljenja
By doing so, the blood flow in the heart and limbs is improved, lowering blood pressure and preventing chest pain (angina pectoris). 
S tem izboljša pretok krvi v srce in okončine, zniža krvni tlak in preprečuje bolečine v prsih (angina pektoris).
Whenever this is the case, the treating physician should be notified immediately, and treatment with nifedipine should be ceased. 
Kadar se to zgodi, je treba nemudoma obvestiti zdravnika, ki vodi zdravljenje, in prekiniti zdravljenje z nifedipinom.
Therefore, monitoring of quinidine plasma levels is recommended. 
Zato je priporočljivo spremljanje plazemskih koncentracij kinidina.
This randomised, double blind, prospective study was carried out on an average population of patients with hypertension that, besides a blood pressure of 150/95 mm Hg or higher or a systolic blood pressure of >160 mm Hg, presented with at least one other cardiovascular risk factor. 
V to randomizirano, dvojno slepo, prospektivno študijo so vključili povprečno populacijo bolnikov s hipertenzijo, ki so imeli najmanj en dejavnik tveganja srčno-žilne bolezni in bodisi krvni tlak 150/95 mm Hg ali več bodisi sistolični krvni tlak >160 mmHg.
In case of life-threatening bradycardia, a temporary cardiac pacemaker can be used. 
V primeru življenjsko ogrožajoče bradikardije lahko uporabimo začasni srčni spodbujevalnik.
In addition, β-sympathomimetics may be given, e.g. 0.2 mg isoprenalin slowly i.v. 
Poleg naštetega lahko damo β-simpatomimetike, npr. 0,2 mg izoprenalina počasi i.v.
Caution should be exercised in patients with hypotension, as there is a risk of further reduction in blood pressure. 
Previdnost je potrebna pri bolnikih s hipotenzijo, saj obstaja nevarnost dodatnega znižanja krvnega tlaka.
MARKETING AUTHORISATION HOLDER Pharmamatch BV 
IMETNIK DOVOLJENJA ZA PROMET Pharmamatch BV
Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. 
Nosečnost in dojenje Posvetujte se z zdravnikom ali farmacevtom, preden vzamete katerokoli zdravilo.
Thus, contraindicating the use of nifedipine in women of childbearing potential, which amounts to contraindicating it from the beginning of the first trimester of pregnancy, should result in a loss of chance in this target population since nifedipine cannot be considered as a teratogenic product. 
Zaradi tega bi kontraindiciranje zdravila nifedipine pri ženskah v rodni dobi, kar ustreza kontraindiciranju tega zdravila od začetka prvega trimesečja nosečnosti, imelo za posledico zmanjšanje možnosti pri tej ciljni populaciji, saj zdravilo nifedipin ne more biti obravnavano kot teratogeno.
nocturnal enuresis, acute, reversible deterioration in renal function in patients with chronic renal insufficiency. 
nočna enureza, akutno, reverzibilno poslabšanje ledvične funkcije pri bolnikih s kronično ledvično insuficienco
Distribution Both nifedipine and its metabolites are mainly bound to plasma protein (92-98%). 
Porazdelitev Nifedipin in njegovi presnovki se v glavnem vežejo na plazemske beljakovine (92-98 %).
It is not known if a pharmacological effect in the infant can occur because of this; however, it is recommended to cease breast feeding as a precautionary measure. 
Ni znano, ali zaradi tega pride do farmakološkega učinka na dojenčka, zato je priporočljivo iz previdnosti prekiniti dojenje.
Medicines that are known to either inhibit or induce this enzyme can therefore alter the absorption (after oral administration) or elimination of nifedipine. 
Zdravila, za katere je znano bodisi zaviranje bodisi induciranje tega encima, lahko torej spremenijo absorpcijo (pri peroralnem jemanju) oz. izločanje nifedipina.
depression. 
depresija
SPECIAL STORAGE CONDITIONS Store in the original packaging. 
POSEBNA NAVODILA ZA SHRANJEVANJE Shranjujte v originalni ovojnini.
After regular intake of grapefruit juice, this effect may last for at least three days after the last ingestion of grapefruit juice. 
Če bolnik redno uživa grenivkin sok, lahko ta učinek traja vsaj še tri dni po zadnjem zaužitju grenivkinega soka.
Moreover, as is the case for all oral administrations, the active substance undergoes a first pass effect. 
Kot pri vseh peroralno uporabljenih zdravilih je zdravilna učinkovina podvržena učinku prvega prehoda.
Moreover, the number of reported symptomatic adverse events was higher in the group treated with nifedipine than in the control group. 
Poleg naštetega je bilo število poročanih simptomatskih neželenih učinkov večje v skupini, ki je bila zdravljena z nifedipinom v primerjavi s kontrolno skupino.
The safety of nifedipine during pregnancy has not been established. 
Varnost nifedipina med nosečnostjo ni ugotovljena.
Elimination of the product and the restoration of stable cardiovascular conditions may be needed. 
Morda bo potrebno odstranjevanje zdravila in obnovitev stabilnega srčno-žilnega stanja.
OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF NIFEDIPINE PHARMAMATCH RETARD 30/60 mg and associated names (See Annex I) 
SPLOŠNI POVZETEK ZNANSTVENEGA VREDNOTENJA ZDRAVILA NIFEDIPINE PHARMAMATCH RETARD 30/60 mg in povezana imena (glejte Dodatek I)
oesophageal reflux in patients with systemic sclerosis, allergic hepatitis, increased portal pressure in patients with alcoholic cirrhosis, transient increase in liver enzymes. 
ezofagealni refluks pri bolnikih s sistemsko sklerozo, alergijski hepatitis, zvišan portalni tlak pri bolnikih z alkoholno cirozo, prehodno zvišanje ravni jetrnih encimov
Nifedipine has a short half-life of approximately 2 - 4 hours. 
Razpolovna doba nifedipina je kratka in znaša od 2 do 4 ure.
Dosage in case of reduced kidney function 
Odmerjanje v primeru motenj delovanja ledvic
Haemodialysis is not useful, since nifedipine cannot be dialysed. 
Hemodializa ni uporabna, saj se nifedipin ne dializira.
In patients with hepatic impairment, the elimination half-life is distinctly prolonged and the total clearance is reduced. 
Pri bolnikih z motnjami delovanja jeter je razpolovna doba izločanja izrazito podaljšana, skupni očistek je zmanjšan.
Nifedipine is contraindicated during pregnancy (See section 4.3). 
Nifedipin je kontraindiciran med nosečnostjo (glejte poglavje 4.3).
PHARMACEUTICAL FORM AND CONTENTS 28 prolonged-release tablets. 
FARMACEVTSKA OBLIKA IN VSEBINA 28 tablet s podaljšanim sproščanjem.
Round, biconvex tablets with a pale red colour. 
Okrogle, bikonveksne tablete bledo rdeče barve.
The results show that Nifedipine Retard demonstrates both a comparable antihypertensive effect and a comparable effect on the above-mentioned composite end-point. 
Rezultati so pokazali, da zdravilo Nifedipine Retard kaže primerljiv antihipertenzivni učinek in primerljiv učinek na zgoraj omenjeni sestavljeni opazovani dogodek.
Hypotension as a result of cardiogenic shock and arterial vasodilatation should be treated with calcium (10-20 ml of calcium gluconate 10% slowly i.v., to be repeated if necessary). 
Hipotenzijo kot posledico kardiogenega šoka in arterijske vazodilatacije zdravimo s kalcijem (1020 ml 10 % kalcijevega glukonata, počasi, i.v., po potrebi ponoviti).
If an insufficient increase in blood pressure is achieved with calcium and isoprenalin, vasoconstricting sympathomimetics such as dopamine or noradrenalin should be administered. 
Če s kalcijem in izoprenalinom ne dosežemo zadostnega zvišanja krvnega tlaka, moramo uporabiti vazokonstrikcijske simpatomimetike, kot je dopamin ali noradrenalin.
There are no adequate data from the use of nifedipine in pregnant women. 
Ni zadostnih podatkov o uporabi nifedipina pri nosečnicah.
Especially for prolonged-release products (Nifedipine Pharmamatch retard) elimination must be as complete as possible, including the small intestine, to prevent the otherwise inevitable subsequent absorption of the active substance. 
Zlasti zdravila s podaljšanim sproščanjem (Nifedipine Pharmamatch retard) je treba odstraniti čimbolj temeljito, kar vključuje tanko črevo, da se prepreči sicer neizogibno naknadno absorpcijo zdravilne učinkovine.
Nifedipine should not be used by women who intend to get pregnant in the near future (see section 4.4). 
Nifedipina ne smejo jemati ženske, ki nameravajo zanositi v bližnji prihodnosti (glejte poglavje 4.4).
gynaecomastia in men over 50 years; reversible at discontinuation of treatment. 
ginekomastija pri moških, starejših od 50 let, ki je reverzibilna po prekinitvi zdravljenja
The duration of action of nifedipine can be shortened. 
V tem primeru se lahko skrajša trajanje delovanja nifedipina.
Nifedipine should be used with caution in patients with (threatening) ischemia of fingers and/or toes, because this can be worsened due to decreased tissue perfusion as a result of a lower perfusion pressure. 
Nifedipin je treba uporabljati previdno pri bolnikih z (grozečo) ishemijo prstov na roki in/ali prstov na nogi, saj se lahko to stanje poslabša zaradi zmanjšane perfuzije skozi tkiva, ki je posledica nižjega perfuzijskega tlaka.
Cardiac effects may include heart block, AV dissociation and asystole, and cardiogenic shock with pulmonary oedema. 
- Učinki na srce lahko vključujejo srčni blok, atrioventrikularno (AV) disociacijo in asistolo ter kardiogeni šok s pljučnim edemom.
Therefore, the tablets are appropriate for once-daily administration. 
Zato so tablete primerne za jemanje enkrat dnevno.
It takes some time (lagtime of 2-4 hours) before the active substance escapes from Nifedipine Pharmamatch retard tablets. 
Nekaj časa traja (zakasnitev 2-4 ure) preden zdravilna učinkovina preide iz tablet zdravila Nifedipine Pharmamatch retard.